Because some patients presented adverse symptoms after injection, the Xiangdan Injection Liquid of batch number 080524, which was produced by Zhejiang Tianrui Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianrui Pharmaceutical"), has been urgently suspended.
On March 25, the reporter learned from the Regional Food and Drug Administration that on March 19, 13 patients in Zhongshan City, Guangdong Province presented clinical symptoms such as shivering and fever after using the above batch number of Xiangdan Injection Liquid. Upon inspection, it was found that the pyrogen test item for this batch number of Xiangdan Injection Liquid was不合格 (non-conforming).